[1] BARTOLI-LEONARD F, ZIMMER J, AIKAWA E. Innate and adaptive immunity: the understudied driving force of heart valve disease[J]. Cardiovasc Res, 2021, 117(13): 2506-2524. [2] ISSA N, BLOT G, CANDELLIER A, et al. Macrophages as key modulators of calcific aortic valve disease[J]. Front Cardiovasc Med, 2025, 12: 1664067. [3] SALEMIZADEHPARIZI F, HUANG P, CHEN M H, et al. The contributions of increased reactive oxygen species and inflammatory macrophages to the development of aortic valve calcification[J]. Free Radic Biol Med, 2025, 241: 64-75. [4] XIAO F, PAN H, YANG D, et al. Identification of TNFα-mediated inflammation as potential pathological marker and therapeutic target for calcification progress of congenital bicuspid aortic valve[J]. Eur J Pharmacol, 2023, 951: 175783. [5] LI L, DUAN X, WANG H, et al.Is cell regeneration and infiltration a double edged sword for porcine aortic valve deterioration? A large cohort of histopathological analysis[J]. BMC Cardiovasc Disord, 2022, 22(1): 336. [6] LYU T, LIU Y, LI B, et al.Single-cell transcriptomics reveals cellular heterogeneity and macrophage-to-mesenchymal transition in bicuspid calcific aortic valve disease[J]. Biol Direct, 2023, 18(1): 35. [7] TAGZIRT M, ROSA M, CORSEAUX D, et al. Modulation of inflammatory M1-macrophages phenotype by valvular interstitial cells[J]. J Thorac Cardiovasc Surg, 2023, 166(5): e377-e389. [8] FÉLIX VÉLEZ N E, TU K, GUO P, et al. Secreted cytokines from inflammatory macrophages modulate sex differences in valvular interstitial cells on hydrogel biomaterials[J]. J Biomed Mater Res A, 2025, 113(3): e37885. [9] KOSTYUNIN A, MUKHAMADIYAROV R, GLUSHKOVA T, et al. Ultrastructural pathology of atherosclerosis, calcific aortic valve disease, and bioprosthetic heart valve degeneration: commonalities and differences[J]. Int J Mol Sci, 2020, 21(20): 7434. [10] MUELLER K A L, LANGNAU C, HARM T, et al.Macrophage migration inhibitory factor promotes thromboinflammation and predicts fast progression of aortic stenosis[J]. Arterioscler Thromb Vasc Biol, 2024, 44(9): 2118-2135. [11] WEN L, LIN X, HU D, et al.Trimethylamine N-oxide aggravates human aortic valve interstitial cell inflammation by regulating the macrophages polarization through a N6-methyladenosine-mediated pathway[J]. Atherosclerosis, 2025, 402: 119109. [12] LIU L, LAN Z, LIU X, et al.NETs accelerate aortic valve calcification by promoting M1 macrophage polarization through the TLR9 signaling pathway[J]. Mol Cell Biochem, 2025, 480(12): 6225-6238. [13] BIAN J H, YUAN C Z, GU J X, et al.TREM2 modulates macrophage pyroptosis and inflammatory responses to ameliorate aortic valve calcification[J]. Int Immunopharmacol, 2025, 149: 114161. [14] LU J, MENG J, WU G, et al.Th1 cells reduce the osteoblast-like phenotype in valvular interstitial cells by inhibiting NLRP3 inflammasome activation in macrophages[J]. Mol Med, 2024, 30(1): 110. [15] KLAUZEN P, BASOVICH L, SHISHKOVA D, et al. Macrophages in calcific aortic valve disease: paracrine and juxtacrine disease drivers[J]. Biomolecules, 2024, 14(12): 1547. [16] RADDATZ M A, HUFFSTATER T, BERSI M R, et al.Macrophages promote aortic valve cell calcification and alter STAT3 splicing[J]. Arterioscler Thromb Vasc Biol, 2020, 40(6): e153-e165. [17] QIN M, CHEN Q, LI N, et al. Shared gene characteristics and molecular mechanisms of macrophages M1 polarization in calcified aortic valve disease[J]. Front Cardiovasc Med, 2023, 9: 1058274. [18] SUMMERHILL V I, MOSCHETTA D, OREKHOV A N, et al. Sex-specific features of calcific aortic valve disease[J]. Int J Mol Sci, 2020, 21(16):5620. [19] KIM A J, XU N, YUTZEY K E. Macrophage lineages in heart valve development and disease[J].Cardiovasc Res, 2021, 117(3): 663-673. [20] SHEN C, FANG R, WANG J, et al.Visfatin aggravates transverse aortic constriction-induced cardiac remodelling by enhancing macrophage-mediated oxidative stress in mice[J]. J Cell Mol Med, 2023, 27(17): 2562-2571. [21] FANG Y, WANG H, LI Y, et al.Identification of key diagnostic and prognostic biomarkers for aortic valve stenosis with coronary artery disease through immunological profiling integrating proteomics, single-cell sequencing, and machine learning[J]. Biochem Biophys Res Commun, 2025, 789: 152855. [22] WEI K, CAO Y, KONG X, et al. Exploration and validation of immune and therapeutic-related hub genes in aortic valve calcification and carotid atherosclerosis[J]. J Inflamm Res, 2024, 17: 6485-6500. [23] LIU C, LIU H, XIE T. Correction: Impact of Fetuin-A, Lp(a), matrix gla proteinand macrophage density on calcific aortic valve disease: a clinical study[J]. Lipids Health Dis, 2023, 22: 57. [24] BENJAMIN E J, BLAHA M J, CHIUVE S E, et al.Heart disease and stroke statistics-2017 update: a report from the American Heart Association[J]. Circulation, 2017, 135(10): e146-e603. [25] XU K, XIE S, HUANG Y, et al. Cell-type transcriptome atlas of human aortic valves reveal cell heterogeneity and endothelial to mesenchymal transition involved in calcific aortic valve disease[J]. Arterioscler Thromb Vasc Biol, 2020, 40(12): 2910-2921. [26] LI G, QIAO W, ZHANG W, et al. The shift of macrophages toward M1 phenotype promotes aortic valvular calcification[J]. J Thorac Cardiovasc Surg, 2017, 153(6): 1318-1327.e1. [27] NADRA I, MASON J C, PHILIPPIDIS P, et al. Proinflammatory activation of macrophages by basic calcium phosphate crystals via protein kinase C and MAP kinase pathways: a vicious cycle of inflammation and arterial calcification?[J]. Circ Res, 2005, 96(12): 1248-1256. [28] MATHIEU P, BOUCHAREB R, BOULANGER M C. Innate and adaptive immunity in calcific aortic valve disease[J]. J Immunol Res, 2015, 2015: 851945. [29] COTÉ N, MAHMUT A, BOSSE Y, et al. Inflammation is associated with the remodeling of calcific aortic valve disease[J]. Inflammation, 2013, 36(3): 573-581. [30] DWECK M R, BOON N A, NEWBY D E. Calcific aortic stenosis: a disease of the valve and the myocardium[J]. J Am Coll Cardiol, 2012, 60(19): 1854-1863. [31] GOODY P R, HOSEN M R, CHRISTMANN D, et al. Aortic valve stenosis: from basic mechanisms to novel therapeutic targets[J]. Arterioscler Thromb Vasc Biol, 2020, 40(4): 885-900. [32] YUTZEY K E, DEMER L L, BODY S C, et al. Calcific aortic valve disease: a consensus summary from the Alliance of Investigators on Calcific Aortic Valve Disease[J]. Arterioscler Thromb Vasc Biol, 2014, 34(11): 2387-2393. [33] RIDKER P M, EVERETT B M, THUREN T, et al. Antiinflammatory therapy with canakinumab for atherosclerotic disease[J]. N Engl J Med, 2017, 377(12): 1119-1131. [34] NAHRENDORF M, SWIRSKI F K. Abandoning M1/M2 for a network model of macrophage function[J]. Circ Res, 2016, 119(3): 414-417. [35] ALLAHVERDIAN S, CHEHROUDI A C, MCMANUS B M, et al. Contribution of intimal smooth muscle cells to cholesterol accumulation and macrophage-like cells in human atherosclerosis[J]. Circulation, 2014, 129(15): 1551-1559. |